$HLIO

HELIOS TECHNOLOGIES, INC. (HLIO): Results of Operations and Financial Condition

HELIOS TECHNOLOGIES, INC. (HLIO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hlio-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE 35 m+ FOR IMMEDIATE RELEASE Helios Technologies Reports Second Quarter 2026 Results; Profitable Sales Growth Momentum Continues, Raising Full Year 2026 Outlook • Grew 2Q26 sales to $232 million, up 9% over prior

Original reporting
Published Aug 10, 2026, 8:57 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HLIO
Bullish
high confidence
Mentioned
$HLIO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HLIOBullishHigh
01

Why it matters

The company delivered strong profitability and cash generation in 2Q26, reduced leverage to multi-year lows, and raised full-year sales and adjusted EBITDA margin ranges, which is typically a catalyst for re-rating and near-term positioning.

02

Market read

Guidance raise plus EPS, margin, and cash-flow beats create a clear near-term trading catalyst for HLIO.

03

What to watch

Electronics segment shows large gross profit and margin expansion, but SEA expenses also rose 22% in Electronics; traders may watch whether cost growth moderates in 3Q26.

Relevance 7/10Novelty 9/10Timing: after-hours filing on Aug 10, 2026 with raised FY2026 and 3Q26 outlook

Background

Helios Technologies filed an SEC 8-K with its 2Q26 results and updated FY2026 and 3Q26 guidance.

Company-level read

Ticker impact

$HLIOBullishHigh confidence
Context

Helios reported 2Q26 sales of $231.9M (+9% YoY), adjusted EPS $0.88 (+49% YoY), and raised FY2026 outlook to $880-$900M sales.

Expected impact

Likely positive near-term bias as traders price in higher FY2026 sales and margin range, with follow-through dependent on 3Q26 outlook.

Evidence & confidence

The filing includes specific GAAP and non-GAAP results, record operating cash flow and free cash flow, leverage reduction to 1.4x, and explicit updated guidance ranges for FY2026 and 3Q26.

Market effects

Signals improving profitability and cash generation in engineered motion control/electronics and hydraulics end-markets, potentially supporting sentiment for similar industrials.

APAC electronics sales rose 43% YoY while hydraulics APAC declined 8%, suggesting mixed regional demand within the company’s segments.

Limited direct macro spillover, but the guidance raise can influence industrial growth expectations for motion-control supply chains.

Counterpoint

The outlook raise is based on constant-currency assumptions and tougher back-half comparisons; investors may discount sustainability if macro/tariff/geopolitical uncertainty worsens.

Key entities

  • Helios Technologies, Inc.

    NYSE-listed motion control and electronic controls company reporting 2Q26 results and raising FY2026 outlook.

  • Sean Bagan

    President and CEO quoted on momentum, margin expansion, cash generation, and outlook confidence.

  • Jeremy Evans

    CFO quoted on 2H execution and the updated FY2026 and 3Q26 guidance ranges.

Related articles

$HLIOMedAI 8/10

Expected Sales In Q2 CY2026, Guides for Strong Full

Helios Technologies (NYSE: HLIO) reported Q2 CY2026 revenue of $231.9 million, up 9.1% year on year and 0.7% above Wall Street estimates. Q2 non-GAAP EPS was $0.88, 9.6% above consensus. Guidance called for next-quarter revenue of $218.5 million at the midpoint. The stock rose 3.2% to $84.34 after results.

$NHIMed

National Health Investors: Q2 Earnings Snapshot

National Health Investors Inc. (NHI) reported Q2 funds from operations of $57.8 million, or $1.19 per share, and net income of $55.6 million, or $1.15 per share, with revenue of $121.3 million. The REIT expects full-year funds from operations of $4.74 to $4.79 per share, according to the company.

$SGRYMed

Surgery Partners: Q2 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q2 loss of $15 million, or 12 cents per share. Adjusted earnings were 10 cents per share, and revenue was $848.9 million. The company expects full-year revenue of $3.35 billion to $3.45 billion, according to its earnings release.

$HTZMedAI 8/10

Why Is Hertz (HTZ) Stock Soaring Today

Hertz (HTZ) shares rose about 12% after the company reported Q2 results that beat analyst expectations and issued upbeat guidance. Hertz posted an adjusted loss of $0.11 per share on $2.4 billion revenue and cited better pricing and improved fleet utilization. For Q3 it forecast positive EPS and adjusted corporate EBITDA of $275 million to $325 million.